It has been over a year since sample collection for COVID-19 diagnostic testing began. Researchers, diagnostics labs, test kit providers and clinical test manufacturers have been working endlessly to find scalable solutions to identify and sequence the SARS-CoV-2 virus that can offer efficiency, reliability, and scalability, thus relieving some of the burden currently resting on health care workers, infrastructure, and donors. Initially, sample collection efforts for COVID-19 focused mainly on the use of nasopharyngeal swabs, requiring trained personnel and an invasive procedure. In 2020, as sample collection expanded to include self-collected saliva, the US Food and Drug Administration (FDA) authorized the use of DNA Genotek's OMNIgene®•ORAL as part of a COVID-19 test kit.

Download the white paper to learn about DNA Genotek’s OMNIgene®•ORAL for scalable saliva self-collection.